Myeloid-Derived Suppressor Cells: Characterization and Expansion in Models of Endotoxemia and Transplantation

Methods in Molecular Biology

Volumn 677, Issue , 2011, Pages 169-180

  Van Rompaey, Nicolas ^a   Le Moine, Alain ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Heme oxygenase 1; Lipopolysaccharide; Myeloid derived suppressor cells; T cells; Transplantation

Indexed keywords

LIPOPOLYSACCHARIDE;

ANIMAL; ARTICLE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; HUMAN; MALE; MOUSE; PATHOLOGY; TRANSPLANTATION;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MYELOID CELLS; TRANSPLANTATION;

EID: 79952198443     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-869-0_12     Document Type: Chapter

References (12)

1. Strober, S. (1984). Natural suppressor (NS) cells, neonatal tolerance, and total lymphoid irradiation: exploring obscure relationships. Annu. Rev. Immunol. 2: 219–237.
2. Ostrand-Rosenberg, S., and P. Sinha. (2009). Myeloid-derived suppressor cells: linking inflammation and cancer. J. Immunol. 182: 4499–4506.
3. Bronte, V., and P. Zanovello. (2005). Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 5: 641–654.
4. Zhang, W., S. Liang, J. Wu, and A. Horuzsko. (2008). Human inhibitory receptor immu-noglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 86: 1125–1134.
5. Ezernitchi, A. V., I. Vaknin, L. Cohen-Daniel, O. Levy, E. Manaster, A. Halabi, E. Pikarsky, L. Shapira, and M. Baniyash. (2006). TCR zeta down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between
6. Almand, B., J. I. Clark, E. Nikitina, J. van Beynen, N. R. English, S. C. Knight, D. P. Carbone, and D. I. Gabrilovich. (2001). Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166: 678–689.
7. Gabrilovich, D. I., and S. Nagaraj. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162–174.
8. Mazzoni, A., V. Bronte, A. Visintin, J. H. Spitzer, E. Apolloni, P. Serafini, P. Zanovello, and D. M. Segal. (2002). Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J. Immunol. 168: 689–695.
9. Nagaraj, S., K. Gupta, V. Pisarev, L. Kinarsky, S. Sherman, L. Kang, D. L. Herber, J. Schneck, and D. I. Gabrilovich. (2007). Altered recognition of antigen is a mechanism of CD8+ T-cell tolerance in cancer. Nat. Med. 13: 828–835.
10. De Wilde, V., N. Van Rompaey, M. Hill, J. F. Lebrun, P. Lemaitre, F. Lhomme, C. Kubjak, B. Vokaer, G. Oldenhove, L. M. Charbonnier, M. C. Cuturi, M. Goldman, and A. Le Moine. (2009). Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am. J. Transplant. 9: 2034–2047.
11. Ryter, S. W., J. Alam, and A. M. Choi. (2006). Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 86: 583–650.
12. Gasser, D. L., and W. K. Silvers. (1972). Genetics and immunology of sex-linked antigens. Adv. Immunol. 15: 215–247.